We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about Ewing sarcoma, a bone cancer primarily affecting children and adolescents. Understand its 'onion skin' appearance on scans, symptoms, diagnosis, and treatment options.
Understanding Ewing Sarcoma: The 'Onion Skin' Sign in Bone Tumors Ewing sarcoma is a rare but serious type of bone cancer that primarily affects children and adolescents. It is the second most common bone cancer in children, following osteosarcoma. While the term 'cancer' can be frightening, understanding its characteristics, symptoms, and treatment options is crucial for early detection and better outcomes. One of the distinctive features noted in imaging scans for Ewing sarcoma is the 'onion skin' appearance of the bone tumors. This article delves into what Ewing sarcoma is, why this specific appearance occurs, its symptoms, how it's diagnosed, the treatment approaches, and the outlook for affected individuals, with a focus on providing clear, practical information for Indian readers. What is Ewing Sarcoma? Ewing sarcoma is a cancer that originates in the bones or the soft tissues surrounding them. It can develop in any bone, but it most commonly appears in the pelvis, the long bones of the legs (like the femur and tibia), and the upper arm bones. This type of cancer is characterized by the rapid growth of abnormal cells that form a tumor. It is more prevalent in individuals under the age of 30, with a peak incidence in children and adolescents. In the United States, about 1 in 3 bone cancers diagnosed are Ewing sarcomas, and approximately 1.5 out of every million children under 15 develop this condition annually. The 'Onion Skin' Appearance: What Does It Mean? When imaging tests such as X-rays, CT scans, or MRIs are performed, Ewing sarcoma tumors can sometimes exhibit an 'onion skin' appearance. This distinctive look is not due to the tumor itself but rather the body's reaction to it. The tumor stimulates the periosteum, which is a thin, membrane-like layer that covers the outer surface of all bones. When the periosteum is irritated or injured by the growing tumor, it can trigger a reactive process. This reaction leads to the formation of new, abnormal bone layers that grow in response to the tumor's presence. These layered growths, stacked one on top of another, resemble the layers of an onion, hence the term 'onion skin appearance'. This finding is a significant clue for radiologists and oncologists in diagnosing Ewing sarcoma, helping to differentiate it from other bone conditions. Symptoms of Ewing Sarcoma Early detection is key for improving the prognosis of Ewing sarcoma. Recognizing the symptoms is the first step. Common signs and symptoms include: Pain at the tumor site: This is often the most common symptom. The pain may be persistent, worsen over time, and can be felt even at rest. It might also be more noticeable at night. Swelling or a lump: A visible or palpable lump or swelling may develop near the affected bone. Fever: Unexplained fever, especially without signs of infection, can be a symptom. Fatigue: A general feeling of tiredness and lack of energy. Unintentional weight loss: Losing weight without trying to diet or exercise. Tenderness: The area around the tumor might be tender to touch. Limited movement: If the tumor is near a joint, it can cause difficulty in moving the limb. It's important to note that these symptoms can also be caused by less serious conditions. However, if these symptoms persist or worsen, it's essential to seek medical attention. Causes and Risk Factors The exact cause of Ewing sarcoma is not fully understood. However, it is known to be associated with specific genetic mutations. In most cases, these mutations occur spontaneously and are not inherited. These genetic changes affect the way cells grow and divide, leading to the formation of tumors. While the genetic basis is complex, certain factors can increase the risk: Age: As mentioned, Ewing sarcoma most commonly affects children and young adults, particularly those under the age of 30. Genetics: While rare, a family history of certain genetic conditions might slightly increase the risk. However, most cases are sporadic. Race: Some studies suggest a slightly higher incidence in individuals of European descent, but it can occur in people of all ethnicities. It's crucial to remember that having a risk factor does not mean a person will develop the cancer, and many people diagnosed with Ewing sarcoma have no known risk factors. Diagnosis of Ewing Sarcoma Diagnosing Ewing sarcoma involves a thorough medical evaluation and a series of tests to confirm the presence and extent of the cancer. The diagnostic process typically includes: Medical History and Physical Examination: The doctor will ask about your symptoms, medical history, and family history. A physical examination will be conducted to check for lumps, swelling, and tenderness. Imaging Tests: These are vital for visualizing the tumor and its impact on the bone and surrounding tissues. X-rays: Often the first imaging test, X-rays can reveal abnormalities in the bone, including the characteristic 'onion skin' appearance. CT Scans (Computed Tomography): Provide detailed cross-sectional images of the body, helping to assess the tumor's size and spread. MRI Scans (Magnetic Resonance Imaging): Excellent for visualizing soft tissues, MRIs can show the extent of the tumor into muscles and other soft tissues, as well as its relationship to nerves and blood vessels. PET Scans (Positron Emission Tomography): Used to detect cancer cells throughout the body and assess if the cancer has spread to other areas (metastasis). Bone Scans: Help identify areas where cancer may have spread to other bones. Biopsy: This is the definitive diagnostic test. A small sample of the tumor tissue is removed either through a needle biopsy or a surgical procedure. The sample is then examined under a microscope by a pathologist to confirm the presence of cancer cells and determine the specific type of sarcoma. The biopsy also helps rule out other conditions like osteosarcoma or infections. Gene Mutation Testing: The cells obtained from the biopsy can be tested for specific genetic mutations that are characteristic of Ewing sarcoma. Identifying these mutations can help confirm the diagnosis and guide treatment decisions. Treatment for Ewing Sarcoma The treatment for Ewing sarcoma is typically aggressive and involves a multidisciplinary approach, often combining several therapies. The goal is to eliminate cancer cells, control the tumor's growth, and prevent its spread. The main treatment modalities include: Chemotherapy: This is usually the first line of treatment. Chemotherapy drugs are administered intravenously to kill cancer cells throughout the body. It can help shrink the tumor before surgery and treat any microscopic cancer cells that may have spread. Surgery: If possible, surgery is performed to remove the tumor. The extent of surgery depends on the tumor's size and location. Limb-sparing surgery aims to remove the tumor while preserving the function of the affected limb. In some cases, amputation might be necessary. Removing the tumor also removes the 'onion skin' appearance from the affected bone. Radiation Therapy: Radiation therapy uses high-energy rays to kill cancer cells. It may be used after surgery to destroy any remaining cancer cells or if the tumor cannot be completely removed by surgery. It can also be used to manage pain in cases of advanced disease. The specific treatment plan will be tailored to the individual patient based on the stage of the cancer, the tumor's location, the patient's age and overall health, and the presence of specific genetic markers. Outlook and Survival Rates The outlook for Ewing sarcoma has improved significantly over the years due to advancements in treatment. The survival rate depends on various factors, including the stage of the cancer at diagnosis, whether it has spread to other parts of the body, the tumor's location, and the patient's response to treatment. According to data from the American Cancer Society, the overall 5-year relative survival rate for Ewing sarcoma was approximately 63% between 2012 and 2018. However, it's crucial to remember that these statistics are based on older data. Advances in chemotherapy, surgical techniques, and targeted therapies mean that current survival rates are likely higher. For localized Ewing sarcoma (cancer that has not spread), the 5-year survival rate can be significantly higher. For metastatic disease (cancer that has spread), the prognosis is more challenging but still offers hope with aggressive treatment. Individual outcomes can also be influenced by factors such as age, genetic makeup, and the overall health of the patient. When to Consult a Doctor It is essential to consult a doctor if you or your child experiences any of the persistent symptoms mentioned above, particularly: Persistent bone pain, especially if it worsens at night or interferes with daily activities. A noticeable lump or swelling on a bone. Unexplained fever, fatigue, or weight loss. Do not delay seeking medical advice. Early diagnosis and prompt treatment are critical for the best possible outcome in cases of Ewing sarcoma. Prevention Currently, there are no known ways to prevent Ewing sarcoma, as it is primarily caused by genetic mutations that occur randomly. However, maintaining a healthy lifestyle, ensuring proper nutrition, and engaging in regular physical activity can contribute to overall well-being and potentially support the body's resilience. Disclaimer: This article provides general information and should not be considered
In summary, timely diagnosis, evidence-based treatment, and prevention-focused care improve long-term health outcomes.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026